[Elsevier] [Supplementary]Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial |
|
This post will be closed automatically in 2026-08-03 17:14
Reward20points
|
post
reply
points
0
10
54671 Prevalence of melasma, impact on quality of life and social stigmatization: results of the first large international survey
50
[Full book]Indian Spices for Type 2 Diabetes Molecular Mechanisms and Pharmacological Insights
10
Understanding microbial mercury methylation via metabolic pathways: Processes associated with one-carbon metabolism
120
FOUR PAPERS FROM LANCET
10
A Retrospective Cohort Study of Optimal Contrast for Successful Intussusception Reduction: Institutional Practices Matter
